Buchumschlag

Prognostic Implications of Myositis‐Specific Autoantibodies on Mortality, Relapse, and Remission in Dermatomyositis Patients

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Ying Hou, Xiaotian Ma, Haoran Mu, Bing Zhao, Guoyong Zhang, Qingsong Fu, Fengyi Zhang, Xuehan Wu, Lining Zhang, Fang Wang, Wenchen Sui, Shuangwu Liu, Wei Li, Yuying Zhao, Chuanzhu Yan, Tingjun Dai, Kai Shao
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	European Journal of Neurology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The Case of a 25‐Year‐Old Woman With Isolated Head Tremor
von: Ying Zhao, et al.
Veröffentlicht: (2025)

Connectivity‐based striatal subregion microstructural changes in sporadic amyotrophic lateral sclerosis patients: Relation to motor disability, cognitive deficits, and serum biomarkers
von: Yujing Chen, et al.
Veröffentlicht: (2024)

The Case of a 19‐Year‐Old Woman Presenting With Headache and Transient Loss of Consciousness
von: Yan Lin, et al.
Veröffentlicht: (2026)

No General Association Between Myositis Antibodies and Electromyography Findings
von: Benedict Kleiser, et al.
Veröffentlicht: (2026)

Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non‐Concurrent Cohort Study
von: Grayson Beecher, et al.
Veröffentlicht: (2025)

Correction to “Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD ?”
Veröffentlicht: (2024)

Relapse‐Associated and Relapse‐Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different Eras
von: Noemi Montobbio, et al.
Veröffentlicht: (2024)

Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy
von: Dietrich Sturm, et al.
Veröffentlicht: (2025)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
von: Massimiliano Calabrese, et al.
Veröffentlicht: (2024)

Concerns Regarding “Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy”
von: Muhammad Owais, et al.
Veröffentlicht: (2025)

Relapses, Comorbidities, and Predictors of Outcome in Anti‐ GABA A Receptor Encephalitis
von: Claudia Papi, et al.
Veröffentlicht: (2026)

A Patient‐Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis
von: Chad Smith, et al.
Veröffentlicht: (2026)

Glycosylation Gene Signatures as Prognostic Biomarkers in Glioblastoma
von: Tong Zhao, et al.
Veröffentlicht: (2025)

Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account
von: Josef Finsterer, et al.
Veröffentlicht: (2025)

Comment on: Associations of Inflammatory Markers With Neurological Dysfunction and Prognosis in Patients With Progressive Stroke
von: Xinmin Zhao, et al.
Veröffentlicht: (2025)

Reply to Owais Et al. Concerns Regarding “Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy”
von: Dietrich Sturm, et al.
Veröffentlicht: (2025)

Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis
von: Ferdinando Clarelli, et al.
Veröffentlicht: (2025)

Pseudorabies Virus‐Associated Encephalitis with Endophthalmitis
von: Fanglan Xing, et al.
Veröffentlicht: (2025)

Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort
von: Samuel S. Bruce, et al.
Veröffentlicht: (2025)

De‐Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in Austria
von: Michael Guger, et al.
Veröffentlicht: (2025)

Monitoring CSF MOG Antibody in a Relapsing Case of MOGAD With Isolated CSF Positivity
von: Ken Ikegami, et al.
Veröffentlicht: (2026)

Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS
von: Katelijn M. Blok, et al.
Veröffentlicht: (2025)

Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis
von: Rosario Vasta, et al.
Veröffentlicht: (2025)

Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis
von: Theodoros Ladopoulos, et al.
Veröffentlicht: (2025)

Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia
von: Ifrah Zawar, et al.
Veröffentlicht: (2024)

Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease
von: Capucine Piat, et al.
Veröffentlicht: (2025)

Real‐World Experience of Sustained‐Release Fampridine in Chinese Patients With Multiple Sclerosis: A Case Series on Walking Impairment and Fatigue
von: Han Wang, et al.
Veröffentlicht: (2025)

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
von: Ralf Gold, et al.
Veröffentlicht: (2026)

Performance of Composite Endpoints Defining Progression Independent of Relapse Activity in Multiple Sclerosis
von: Ludwig Kappos, et al.
Veröffentlicht: (2025)

The Prognostic Factors in Children With Status Epilepticus and Status Epilepticus Severity Score Scales
von: Serap Bilge, et al.
Veröffentlicht: (2025)

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis
von: Federico Ranieri, et al.
Veröffentlicht: (2025)

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD
von: Sean J. Pittock, et al.
Veröffentlicht: (2026)

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
von: F. Shawket, et al.
Veröffentlicht: (2026)

The Role of Electroencephalography in Predicting Post‐Stroke Seizures and an Updated Prognostic Model ( SeLECT ‐ EEG )
von: Kai Michael Schubert, et al.
Veröffentlicht: (2025)

Diagnostic and Prognostic Utility of Plasma p‐tau217 for Alzheimer's Disease in Chinese Elderly: Insights From the SILCODE Study With a Derived Threshold
von: Ruixian Li, et al.
Veröffentlicht: (2026)

Reply to “The Role of EEG in Predicting Post‐Stroke Seizures and an Updated Prognostic Model ( SeLECT ‐ EEG )”
von: Kai Michael Schubert, et al.
Veröffentlicht: (2025)

Letter on the Role of Electroencephalography in Predicting Post‐Stroke Seizures and an Updated Prognostic Model (SeLECT‐EEG)
von: Guicheng Kuang, et al.
Veröffentlicht: (2025)

Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022
von: Milla Laine, et al.
Veröffentlicht: (2026)

Blood Lactate as a Prognostic Biomarker for Survival and Weight Loss in Amyotrophic Lateral Sclerosis: An Exploratory–Validation Study
von: Ryutaro Nakamura, et al.
Veröffentlicht: (2026)

Serum p‐tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder
von: Shijun Yan, et al.
Veröffentlicht: (2025)